EHCS Relative Valuation - European Healthcare Acquisition & Growth Company BV - Alpha Spread
E

European Healthcare Acquisition & Growth Company BV
AEX:EHCS

Watchlist Manager
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
Watchlist
Price: 9.9 EUR 1.02%
Market Cap: 83m EUR
Have any thoughts about
European Healthcare Acquisition & Growth Company BV?
Write Note
Section:
 

Relative Value

The Relative Value of one EHCS stock under the Base Case scenario is 2.95 EUR. Compared to the current market price of 9.9 EUR, European Healthcare Acquisition & Growth Company BV is Overvalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EHCS Relative Value
Base Case
2.95 EUR
Overvaluation 70%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.2
More Details
3
P/E
P/E
Price to Earnings
3
vs History
0
vs Industry
35
Median 3Y
0
Median 5Y
0
Industry
16.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
14.8
More Details
41.2
P/B
P/B
Price to Book Value
41.2
vs History
16
vs Industry
2
Median 3Y
-10.7
Median 5Y
-10.7
Industry
1.6
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3.2
More Details
10.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.7
vs History
0
vs Industry
32
Median 3Y
0
Median 5Y
0
Industry
6.8
More Details
21.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.3
vs History
0
vs Industry
9
Median 3Y
0
Median 5Y
0
Industry
11.2
More Details
21.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.3
vs History
0
vs Industry
10
Median 3Y
0
Median 5Y
0
Industry
13.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
6
Median 3Y
0
Median 5Y
0
Industry
11.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
6
Median 3Y
0
Median 5Y
0
Industry
12.7
More Details
98.1
EV/IC
EV/IC
Enterprise Value to IC
98.1
vs History
16
vs Industry
3
Median 3Y
-46
Median 5Y
-46
Industry
1.5
More Details

Multiples Across Competitors

EHCS Competitors Multiples
European Healthcare Acquisition & Growth Company BV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
78.3m EUR 0 3 21.3 21.3
US
Texas Gulf Energy Inc
OTC:TXGE
3.1T USD 249 685 -1 705 864 -615 122.7 -585 689.8
UK
Shaftesbury Capital PLC
JSE:SHC
3T Zac 0 0 0 0
CA
Advance Lithium Corp
XTSX:AALI
540.8B CAD 0 -149 874.8 -833 504.3 -833 504.3
US
Gould Investors LP
OTC:GDVTZ
245.5B USD 0 0 0 0
IN
Aaswa Trading and Exports Ltd
BSE:512038
12.6T INR 246.8 360.8 292 872.8 292 872.8
NL
Nepi Rockcastle NV
JSE:NRP
87.2B Zac 0 0 0 0
US
MCX Technologies Corp
XTSX:MCX
116.9B CAD 0 -734 444.6 -545 223.5 -545 223.5
US
GE Vernova LLC
NYSE:GEV
67.2B USD 0 0 0 0
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
752.4T IDR 24.3 195.9 67.2 67.2
US
Coupang Inc
F:788
38.4B EUR 1.6 40.8 59.1 124.8
EV/EBITDA Multiple
EBITDA Growth
DE
E
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
Average EV/EBITDA: 73 255.1
21.3
N/A
US
T
Texas Gulf Energy Inc
OTC:TXGE
Negative Multiple: -615 122.7 N/A
UK
S
Shaftesbury Capital PLC
JSE:SHC
Not Available
52%
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -833 504.3 N/A
US
G
Gould Investors LP
OTC:GDVTZ
Not Available N/A
IN
A
Aaswa Trading and Exports Ltd
BSE:512038
292 872.8
N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
22%
US
MCX Technologies Corp
XTSX:MCX
Negative Multiple: -545 223.5 N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
738%
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
67.2
N/A
US
Coupang Inc
F:788
59.1
261%
EV/EBIT Multiple
EBIT Growth
DE
E
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
Average EV/EBIT: 73 271.5
21.3
N/A
US
T
Texas Gulf Energy Inc
OTC:TXGE
Negative Multiple: -585 689.8 N/A
UK
S
Shaftesbury Capital PLC
JSE:SHC
Not Available
45%
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -833 504.3 N/A
US
G
Gould Investors LP
OTC:GDVTZ
Not Available N/A
IN
A
Aaswa Trading and Exports Ltd
BSE:512038
292 872.8
N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
40%
US
MCX Technologies Corp
XTSX:MCX
Negative Multiple: -545 223.5 N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
67.2
N/A
US
Coupang Inc
F:788
124.8
330%

See Also

Summary
EHCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
EHCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EHCS stock valuation using valuation multiples.
Wall Street Estimates
EHCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EHCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 179,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.